tci Medicare Compliance & Reimbursement - 2016 Issue 6

Why New Part B Drug Model Could Hit Oncology the Hardest

Could prior studies have already proven opposite results? Oncologist organizations have been especially vocal in their dissent concerning the recent proposed rule to makeover the way Medicare Part B pays for prescription drugs provided in physician offices and hospital outpatient departments. The reason, in part, is due to the high prevalence of oncology-related and expensive drugs paid under Part B. “Medicare beneficiaries comprise 60 percent of the 14 million Americans living with cancer, and the elderly are 10 times more likely to get cancer than the younger population,” stated a Feb. 25 letter from the American SocietyofClinicalOncology...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.